<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>www.pharmablog.nl</title>
	<atom:link href="http://pharmablog.nl/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmablog.nl</link>
	<description>Weblog met nieuws over de pharmaceutische industrie</description>
	<pubDate>Fri, 30 Jul 2010 02:30:21 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6</generator>
	<language>en</language>
			<item>
		<title>Cubicin (daptomycin): Drug Safety Communication -  Risk of  Eosinophilic Pneumonia</title>
		<link>http://pharmablog.nl/blog/2010/07/30/cubicin-daptomycin-drug-safety-communication-risk-of-eosinophilic-pneumonia/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/cubicin-daptomycin-drug-safety-communication-risk-of-eosinophilic-pneumonia/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medicijnen Nieuws]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/cubicin-daptomycin-drug-safety-communication-risk-of-eosinophilic-pneumonia/</guid>
		<description><![CDATA[Audience: Infectious Disease,&#160;Pulmonology [Posted 07/29/2010]
ISSUE:&#160; FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous&#8230;



Audience: Infectious Disease,&#160;Pulmonology [Posted 07/29/2010]
ISSUE:&#160; FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous&#8230;



Lees meer..
]]></description>
			<content:encoded><![CDATA[<p>Audience: Infectious Disease,&nbsp;Pulmonology [Posted 07/29/2010]</p>
<p>ISSUE:&nbsp; FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous&#8230;</p>
<p><a href="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/0/da"><img src="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/0/di" border="0"></img></a><br />
<a href="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/1/da"><img src="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/1/di" border="0"></img></a></p>
<p><img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/B62GJ-zLibw" height="1" width="1" /><br />
Audience: Infectious Disease,&nbsp;Pulmonology [Posted 07/29/2010]</p>
<p>ISSUE:&nbsp; FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous&#8230;</p>
<p><a href="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/0/da"><img src="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/0/di" border="0"></img></a><br />
<a href="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/1/da"><img src="http://feedads.g.doubleclick.net/~a/2ojrPgpFrRoAIC1o9mlnpfwQ1aQ/1/di" border="0"></img></a></p>
<p><img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/B62GJ-zLibw" height="1" width="1" /><br />
<a href="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/B62GJ-zLibw/cubicin-daptomycin-safety-communication-risk-eosinophilic-pneumonia-12771.html">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/cubicin-daptomycin-drug-safety-communication-risk-of-eosinophilic-pneumonia/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Evamist (estradiol transdermal spray): Drug Safety Communication - Unintended Exposure of Children and Pets to Topical Estrogen</title>
		<link>http://pharmablog.nl/blog/2010/07/30/evamist-estradiol-transdermal-spray-drug-safety-communication-unintended-exposure-of-children-and-pets-to-topical-estrogen/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/evamist-estradiol-transdermal-spray-drug-safety-communication-unintended-exposure-of-children-and-pets-to-topical-estrogen/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medicijnen Nieuws]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/evamist-estradiol-transdermal-spray-drug-safety-communication-unintended-exposure-of-children-and-pets-to-topical-estrogen/</guid>
		<description><![CDATA[Audience: OB/GYN, Patient [Posted 07/29/2010]
ISSUE:&#160;FDA notified healthcare professionals and patients that it is reviewing reports of adverse effects from Evamist, an estrogen hormone&#160;used to reduce hot flashes during menopause&#8230;.



Audience: OB/GYN, Patient [Posted 07/29/2010]
ISSUE:&#160;FDA notified healthcare professionals and patients that it is reviewing reports of adverse effects from Evamist, an estrogen hormone&#160;used to reduce hot flashes [...]]]></description>
			<content:encoded><![CDATA[<p>Audience: OB/GYN, Patient [Posted 07/29/2010]</p>
<p>ISSUE:&nbsp;FDA notified healthcare professionals and patients that it is reviewing reports of adverse effects from Evamist, an estrogen hormone&nbsp;used to reduce hot flashes during menopause&#8230;.</p>
<p><a href="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/0/da"><img src="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/0/di" border="0"></img></a><br />
<a href="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/1/da"><img src="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/1/di" border="0"></img></a></p>
<p><img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/YT0PcAMcinA" height="1" width="1" /><br />
Audience: OB/GYN, Patient [Posted 07/29/2010]</p>
<p>ISSUE:&nbsp;FDA notified healthcare professionals and patients that it is reviewing reports of adverse effects from Evamist, an estrogen hormone&nbsp;used to reduce hot flashes during menopause&#8230;.</p>
<p><a href="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/0/da"><img src="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/0/di" border="0"></img></a><br />
<a href="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/1/da"><img src="http://feedads.g.doubleclick.net/~a/iF7GFKe-q5__gTSvcPAIaHUAaqo/1/di" border="0"></img></a></p>
<p><img src="http://feeds.feedburner.com/~r/Drugscom-FdaMedwatchAlerts/~4/YT0PcAMcinA" height="1" width="1" /><br />
<a href="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/YT0PcAMcinA/evamist-estradiol-transdermal-safety-communication-unintended-exposure-children-pets-topical-12770.html">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/evamist-estradiol-transdermal-spray-drug-safety-communication-unintended-exposure-of-children-and-pets-to-topical-estrogen/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Rite Aid Agrees To Pay $1 Million To Settle Medical Privacy Questions</title>
		<link>http://pharmablog.nl/blog/2010/07/30/rite-aid-agrees-to-pay-1-million-to-settle-medical-privacy-questions/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/rite-aid-agrees-to-pay-1-million-to-settle-medical-privacy-questions/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Pharmaceuten]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/rite-aid-agrees-to-pay-1-million-to-settle-medical-privacy-questions/</guid>
		<description><![CDATA[The Wall Street Journal: &#8220;Rite Aid Corp. agreed to pay $1 million to settle potential violations of government privacy rules after regulators said it failed to protect customers&#8217; and employees&#8217; financial and medical information&#8230;
Lees meer..
]]></description>
			<content:encoded><![CDATA[<p>The Wall Street Journal: &#8220;Rite Aid Corp. agreed to pay $1 million to settle potential violations of government privacy rules after regulators said it failed to protect customers&#8217; and employees&#8217; financial and medical information&#8230;<br />
<a href="http://mnt.to/f/3GKp">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/rite-aid-agrees-to-pay-1-million-to-settle-medical-privacy-questions/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Dispensary Of Hope Welcomes Sanofi-Aventis U.S. As Latest Participant In The Continued Access Program</title>
		<link>http://pharmablog.nl/blog/2010/07/30/dispensary-of-hope-welcomes-sanofi-aventis-us-as-latest-participant-in-the-continued-access-program-2/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/dispensary-of-hope-welcomes-sanofi-aventis-us-as-latest-participant-in-the-continued-access-program-2/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Pharmaceuten]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/dispensary-of-hope-welcomes-sanofi-aventis-us-as-latest-participant-in-the-continued-access-program-2/</guid>
		<description><![CDATA[The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary&#8217;s Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn&#8217;t afford&#8230;
Lees meer..
]]></description>
			<content:encoded><![CDATA[<p>The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary&#8217;s Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn&#8217;t afford&#8230;<br />
<a href="http://mnt.to/f/3GKS">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/dispensary-of-hope-welcomes-sanofi-aventis-us-as-latest-participant-in-the-continued-access-program-2/feed/</wfw:commentRss>
		</item>
		<item>
		<title>What Are Proteins? What Is A Protein? How Much Protein Do I Need?</title>
		<link>http://pharmablog.nl/blog/2010/07/30/what-are-proteins-what-is-a-protein-how-much-protein-do-i-need/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/what-are-proteins-what-is-a-protein-how-much-protein-do-i-need/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Bio Industrie]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/what-are-proteins-what-is-a-protein-how-much-protein-do-i-need/</guid>
		<description><![CDATA[Proteins are large molecules consisting of amino acids which our bodies and the cells in our bodies need to function properly. Our body structures, functions, the regulation of the body&#8217;s cells, tissues and organs cannot exist without proteins. Our muscles, skin, bones and many other parts of the body contain significant amounts of protein. Protein [...]]]></description>
			<content:encoded><![CDATA[<p>Proteins are large molecules consisting of amino acids which our bodies and the cells in our bodies need to function properly. Our body structures, functions, the regulation of the body&#8217;s cells, tissues and organs cannot exist without proteins. Our muscles, skin, bones and many other parts of the body contain significant amounts of protein. Protein accounts for 20% of total body weight&#8230;<br />
<a href="http://mnt.to/f/3GLJ">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/what-are-proteins-what-is-a-protein-how-much-protein-do-i-need/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Biology, Computer Science Combine Efforts To Fight Cancer</title>
		<link>http://pharmablog.nl/blog/2010/07/30/biology-computer-science-combine-efforts-to-fight-cancer/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/biology-computer-science-combine-efforts-to-fight-cancer/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Bio Industrie]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/biology-computer-science-combine-efforts-to-fight-cancer/</guid>
		<description><![CDATA[The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer. The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees [...]]]></description>
			<content:encoded><![CDATA[<p>The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer. The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state&#8217;s new billion-dollar war on cancer&#8230;<br />
<a href="http://mnt.to/f/3GH8">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/biology-computer-science-combine-efforts-to-fight-cancer/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Pioneer In &#8216;Ultraslow-Motion&#8217; Imaging Receives American Chemical Society&#8217;s Highest Honor</title>
		<link>http://pharmablog.nl/blog/2010/07/30/pioneer-in-ultraslow-motion-imaging-receives-american-chemical-societys-highest-honor/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/pioneer-in-ultraslow-motion-imaging-receives-american-chemical-societys-highest-honor/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Bio Industrie]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/pioneer-in-ultraslow-motion-imaging-receives-american-chemical-societys-highest-honor/</guid>
		<description><![CDATA[Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry &#38; Professor of Physics at the California Institute of Technology, has been named winner of the 2011 Priestley Medal by the American Chemical Society (ACS)&#8230;
Lees meer..
]]></description>
			<content:encoded><![CDATA[<p>Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry &amp; Professor of Physics at the California Institute of Technology, has been named winner of the 2011 Priestley Medal by the American Chemical Society (ACS)&#8230;<br />
<a href="http://mnt.to/f/3GHb">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/pioneer-in-ultraslow-motion-imaging-receives-american-chemical-societys-highest-honor/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Water Purification Using Nanotechnology</title>
		<link>http://pharmablog.nl/blog/2010/07/30/water-purification-using-nanotechnology/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/water-purification-using-nanotechnology/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Bio Industrie]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/water-purification-using-nanotechnology/</guid>
		<description><![CDATA[Nanotechnology refers to a broad range of tools, techniques and applications that simply involve particles on the approximate size scale of a few to hundreds of nanometers in diameter. Particles of this size have some unique physicochemical and surface properties that lend themselves to novel uses&#8230;
Lees meer..
]]></description>
			<content:encoded><![CDATA[<p>Nanotechnology refers to a broad range of tools, techniques and applications that simply involve particles on the approximate size scale of a few to hundreds of nanometers in diameter. Particles of this size have some unique physicochemical and surface properties that lend themselves to novel uses&#8230;<br />
<a href="http://mnt.to/f/3GKP">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/water-purification-using-nanotechnology/feed/</wfw:commentRss>
		</item>
		<item>
		<title>NRC, UOttawa Scientists First To Watch A Chemical Bond Break Using Molecule&#8217;s Electrons</title>
		<link>http://pharmablog.nl/blog/2010/07/30/nrc-uottawa-scientists-first-to-watch-a-chemical-bond-break-using-molecules-electrons/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/nrc-uottawa-scientists-first-to-watch-a-chemical-bond-break-using-molecules-electrons/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Bio Industrie]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/nrc-uottawa-scientists-first-to-watch-a-chemical-bond-break-using-molecules-electrons/</guid>
		<description><![CDATA[Scientists at the National Research Council of Canada (NRC) and the University of Ottawa (uOttawa) enjoyed a bird&#8217;s eye view of a chemical bond as it breaks. The making and breaking of chemical bonds underlie the biochemical processes of life itself&#8230;
Lees meer..
]]></description>
			<content:encoded><![CDATA[<p>Scientists at the National Research Council of Canada (NRC) and the University of Ottawa (uOttawa) enjoyed a bird&#8217;s eye view of a chemical bond as it breaks. The making and breaking of chemical bonds underlie the biochemical processes of life itself&#8230;<br />
<a href="http://mnt.to/f/3GKV">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/nrc-uottawa-scientists-first-to-watch-a-chemical-bond-break-using-molecules-electrons/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Treating Severe Pain With Sea Snail Saliva</title>
		<link>http://pharmablog.nl/blog/2010/07/30/treating-severe-pain-with-sea-snail-saliva/</link>
		<comments>http://pharmablog.nl/blog/2010/07/30/treating-severe-pain-with-sea-snail-saliva/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 02:30:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Bio Industrie]]></category>

		<guid isPermaLink="false">http://pharmablog.nl/blog/2010/07/30/treating-severe-pain-with-sea-snail-saliva/</guid>
		<description><![CDATA[Scientists have developed a new version of a medication, first isolated from the saliva of sea snails, that could be taken in pill form to relieve the most severe forms of pain as effectively as morphine but without risking addiction. An article on the topic appears in the current issue of Chemical &#38; Engineering News [...]]]></description>
			<content:encoded><![CDATA[<p>Scientists have developed a new version of a medication, first isolated from the saliva of sea snails, that could be taken in pill form to relieve the most severe forms of pain as effectively as morphine but without risking addiction. An article on the topic appears in the current issue of Chemical &amp; Engineering News (C&amp;EN), ACS&#8217; weekly newsmagazine&#8230;<br />
<a href="http://mnt.to/f/3GJP">Lees meer..</a></p>
]]></content:encoded>
			<wfw:commentRss>http://pharmablog.nl/blog/2010/07/30/treating-severe-pain-with-sea-snail-saliva/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
